These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7939273)

  • 21. Bone marrow engraftment following unrelated donor transplantation utilizing busulfan and cyclophosphamide preparatory chemotherapy.
    Klein JL; Avalos BR; Belt P; Taylor CA; Ezzone SA; Scholl MD; Fisher J; Young D; Copelan EA
    Bone Marrow Transplant; 1996 Apr; 17(4):479-83. PubMed ID: 8722342
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of leukemia with partially matched related bone marrow transplantation.
    Munn RK; Henslee-Downey PJ; Romond EH; Marciniak EJ; Fleming DR; Messino MJ; Macdonald JS; Rayens MK; Harder EJ; Phillips GL; Thompson JS
    Bone Marrow Transplant; 1997 Mar; 19(5):421-7. PubMed ID: 9052906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chronic graft-versus-host disease in children and adolescents after bone marrow transplantation from HLA-matched donors.
    Yumura-Yagi K; Inoue M; Sakata N; Okamura T; Yasui M; Nakano T; Nomura K; Nakano T; Park DY; Endo C; Nishiuchi R; Sawada A; Matsuda Y; Oota H; Yoshimoto T; Kawa-Ha K
    Int J Hematol; 2000 Apr; 71(3):278-82. PubMed ID: 10846836
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone marrow transplantation in childhood acute lymphoblastic leukemia with closely matched family donors in Hong Kong.
    Yuen PM; Chik KW; Li CK; Shing MM; Lai H
    Transplant Proc; 1996 Jun; 28(3):1748-9. PubMed ID: 8658866
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone marrow transplantation from unrelated donors: the Italian experience. GITMO, AIEOP and IBMDR.
    Lanino E; Lamparelli T; Dini G; Alessandrino EP; Aversa F; Calori E; Medugno D; Garbarino L; Locatelli F; Marenco P
    Bone Marrow Transplant; 1993; 11 Suppl 1():88-9. PubMed ID: 8448560
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Allogeneic stem cell transplantation in first complete remission enhances graft-versus-leukemia effect in adults with acute lymphoblastic leukemia: antileukemic activity of chronic graft-versus-host disease.
    Lee S; Cho BS; Kim SY; Choi SM; Lee DG; Eom KS; Kim YJ; Kim HJ; Min CK; Cho SG; Kim DW; Lee JW; Min WS; Shin WS; Kim CC
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1083-94. PubMed ID: 17697971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second infusion of bone marrow for treatment of graft failure after allogeneic bone marrow transplantation.
    Davies SM; Weisdorf DJ; Haake RJ; Kersey JH; McGlave PB; Ramsay NK; Blazar BR
    Bone Marrow Transplant; 1994 Jul; 14(1):73-7. PubMed ID: 7951123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A comparative study of unrelated donor bone marrow transplantation and peripheral blood stem cell transplantation for their therapeutic effects on leukemia].
    Fan ZP; Yang K; Liu QF; Sun J; Xu D; Zhang Y; Wei YQ; Ye CX; Jiang QL; Meng FY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Oct; 26(10):1494-7, 1512. PubMed ID: 17062361
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of engraftment in recipients of matched sibling of unrelated donor marrow allografts.
    Davies SM; Ramsay NK; Haake RJ; Kersey JH; Weisdorf DJ; McGlave PB; Blazar BR
    Bone Marrow Transplant; 1994 Jan; 13(1):51-7. PubMed ID: 8019453
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
    Ringdén O; Schaffer M; Le Blanc K; Persson U; Hauzenberger D; Abedi MR; Olerup O; Ljungman P; Remberger M
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):128-34. PubMed ID: 14750078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparable long-term survival after bone marrow versus peripheral blood progenitor cell transplantation from matched unrelated donors in children with hematologic malignancies.
    Meisel R; Laws HJ; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Schmitz M; Fischer J; Göbel U; Enczmann J; Dilloo D
    Biol Blood Marrow Transplant; 2007 Nov; 13(11):1338-45. PubMed ID: 17950920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low incidence of acute graft versus host disease in Thai patients after allogeneic bone marrow transplantation.
    Jootar S; Intragumtornchai T; Chuncharunee S; Seksan P; Hathirat P
    Transplant Proc; 1994 Aug; 26(4):2354-6. PubMed ID: 8066773
    [No Abstract]   [Full Text] [Related]  

  • 33. HLA-mismatched bone marrow transplantation in thalassemia.
    Polchi P; Galimberti M; Lucarelli G; Baronciani D; Giardini C; Angelucci E; De Biagi M; Donati M
    Bone Marrow Transplant; 1993; 12 Suppl 1():67-9. PubMed ID: 8374569
    [No Abstract]   [Full Text] [Related]  

  • 34. Cyclosporine in bone marrow transplantation.
    Speck B; Gratwohl A; Tichelli A; Nissen C
    Transplant Proc; 1992 Aug; 24(4 Suppl 2):88-90. PubMed ID: 1496697
    [No Abstract]   [Full Text] [Related]  

  • 35. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term disease-free survival in acute leukemia patients recovering with increased gammadelta T cells after partially mismatched related donor bone marrow transplantation.
    Godder KT; Henslee-Downey PJ; Mehta J; Park BS; Chiang KY; Abhyankar S; Lamb LS
    Bone Marrow Transplant; 2007 Jun; 39(12):751-7. PubMed ID: 17450185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhancement of BMT management in children and adults.
    Torlontano G; Di Girolamo G; Di Bartolomeo P; Angrilli F; Papalinetti G; Olioso P; Dragani A; Fioritoni G; Iacone A; D'Antonio D
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():59-60. PubMed ID: 2516756
    [No Abstract]   [Full Text] [Related]  

  • 38. Allogeneic cell-mediated immunotherapy using donor lymphocytes for prevention of relapse in patients treated with allogeneic bone marrow transplantation for hematological malignancies.
    Naparstek E; Nagler A; Or R; Kapelushnik J; Slavin S
    Clin Transpl; 1996; ():281-90. PubMed ID: 9286578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Economic analysis of unrelated allogeneic bone marrow transplantation: results from the randomized clinical trial of T-cell depletion vs unmanipulated grafts for the prevention of graft-versus-host disease.
    de Lissovoy G; Hurd D; Carter S; Beatty P; Ewell M; Henslee-Downey J; Kernan N; Yanovich S; Weisdorf D
    Bone Marrow Transplant; 2005 Sep; 36(6):539-46. PubMed ID: 16044144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Bone marrow transplantation in thalassemia].
    Lucarelli G; Galimberti M; Polchi P; Angelucci E; Baronciani D; Giardini C; Durazzi SM; Agostinelli F; Giorgi C; Donati M
    Haematologica; 1991 Jun; 76 Suppl 3():51-7. PubMed ID: 1752543
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.